The DOI matches its Crossref record; 6 of the 7 references it cites were found in a registry or an index.
‘Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19
Open accessAbstract
Large numbers of people are being discharged from hospital following COVID-19 without assessment of recovery. In 384 patients (mean age 59.9 years; 62% male) followed a median 54 days post discharge, 53% reported persistent breathlessness, 34% cough and 69% fatigue. 14.6% had depression. In those discharged with elevated biomarkers, 30.1% and 9.5% had persistently elevated d-dimer and C reactive protein, respectively. 38% of chest radiographs remained abnormal with 9% deteriorating. Systematic follow-up after hospitalisation with COVID-19 identifies the trajectory of physical and psychological symptom burden, recovery of blood biomarkers and imaging which could be used to inform the need for rehabilitation and/or further investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“whereas lower rates of depression (15 percent) also have been reported after hospitalization for COVID-19 (8).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Persistent Symptoms in Patients After Acute COVID-19
Carfì, A., Bernabei, R., Landi, F., & for the Gemelli Against COVID-19 Post-Acute Care Study Group (2020) · JAMA · doi:10.1001/jama.2020.12603 · Cited by 4,561
Halpin, S. J., McIvor, C., Whyatt, G., Adams, A., Harvey, O., McLean, L., Walshaw, C., Kemp, S., Corrado, J., Singh, R., et al. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26368 · Cited by 1,402
Abnormal pulmonary function in COVID-19 patients at time of hospital discharge
Mo, X., Jian, W., Su, Z., Chen, M., Peng, H., Peng, P., Lei, C., Chen, R., Zhong, N., & Li, S. (2020) · European Respiratory Journal · doi:10.1183/13993003.01217-2020 · Cited by 810
Iba, T., Levy, J. H., Levi, M. M., & Thachil, J. V. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14975 · Cited by 610
Hui, D. S. C. (2005) · Thorax · doi:10.1136/thx.2004.030205 · Cited by 525 · cited 1×
“These data are compatible with studies reporting longerterm abnormalities in SARS survivors [6], and initial data emerging from smaller COVID-19 cohorts [1, 7].”
Analysis of thin-section CT in patients with coronavirus disease (COVID-19) after hospital discharge
Wei, J., Yang, H., Lei, P., Fan, B., Qiu, Y., Zeng, B., Yu, P. C., Lv, J., Jian, Y., & Wan, C. (2020) · Journal of X-Ray Science and Technology · doi:10.3233/xst-200685 · Cited by 111 · cited 1×
“Initial reports are emerging of significant on-going symptom burden [1] termed ‘Long-COVID’, and of changes in lung function [2] and imaging [3].”
Cited by
Sorted by citations
Items 501–600 of 860
Joseph, G., Cohen, C., Rubin, C., Murad, H., Indenbaum, V., Asraf, K., Weiss-Ottolenghi, Y., Segal‐Lieberman, G., Kreiss, Y., Lustig, Y., et al. (2023) · Microorganisms · doi:10.3390/microorganisms11071628 · Cited by 7
“Most symptoms were respiratory, manifested mostly as shortness of breath or chronic coughing, as reported by others [44,45].”
BackgroundLathouwers, E., Radwan, A., Blommaert, J., Stas, L., Tassignon, B., Allard, S. D., Ridder, F. D., Waele, E. D., Hoornaert, N., Lacor, P., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-42429-y · Cited by 8
Can Galectin-3 be a reliable predictive biomarker for post-COVID syndrome development?
Portacci, A., Amendolara, M., Quaranta, V. N., Iorillo, I., Buonamico, E., Diaferia, F., Quaranta, S., Locorotondo, C., Schirinzi, A., Boniello, E., et al. (2024) · Respiratory Medicine · doi:10.1016/j.rmed.2024.107628 · Cited by 5
Hsu, Y., Chen, P., Tsai, Y., Wei, C.-H., Wu, L. S.-H., Hsieh, K., Hsieh, M.-H., Lai, H., Lin, C., Lin, H., et al. (2024) · Vaccines · doi:10.3390/vaccines12080910 · Cited by 5
“These markers may suggest an uncontrolled inflammatory response as a potential contributor to the development of PASC [40,41].”
BackgroundBielecka-Dabrowa, A. M., Kapusta, J., Sakowicz, A., Banach, M., Jankowski, P., & Chudzik, M. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13247829 · Cited by 5
“The most commonly reported symptoms include fatigue, muscle weakness, shortness of breath, and joint or chest pain, as well as difficulty concentrating and memory disorders [3,4].”
Gierthmuehlen, M., & Gierthmuehlen, P. C. (2025) · PLoS ONE · doi:10.1371/journal.pone.0315606 · Cited by 5
“Overactivation of mast cells also seems to play a possible role in the development of long-term Covid [29], while D-dimer and C-reactive protein levels also appear to correlate with the occurrence of fatigue during the long-term Covid phase [30].”
Multiple simultaneous embolic cerebral infarctions 11 months after COVID-19
Advani, R., Strømsnes, T. A., Stjernstrøm, E., & Lugg, S. T. (2021) · Thrombosis Journal · doi:10.1186/s12959-021-00304-8 · Cited by 5
“Studies have previously shown D-dimer to be elevated in a sub-set of COVID-19 patients at follow up [3].”
ResultPharmacotherapy of Mental Disorders Associated with COVID-19
Khaustova, O. O., & Чабан, О. (2021) · Психиатрия психотерапия и клиническая психология · doi:10.34883/pi.2021.12.1.008 · Cited by 5
Post-Acute Sequelae of SARS-COVID-2 Syndrome: Just the Beginning
Rezkalla, S. H., & Kloner, R. A. (2021) · Cardiology Research · doi:10.14740/cr1290 · Cited by 5
“Follow-up of 384 patients who were studied in the United Kingdom for 2 months after contracting COVID-19 showed that 53% of patients complained of persistent shortness of breath, 34% continued to have a cough, and about 70% continued to complain of fatigue [14].”
BackgroundThede, C. (2021) · Chinesische Medizin / Chinese Medicine · doi:10.1007/s00052-021-00023-3 · Cited by 5
“Am häufigsten werden Schwächezustände beschrieben, die dem bereits bekannten Chronic-Fatigue-Syndrom ähneln, gefolgt von Atemnot, Husten und depressiven Zuständen (Manal et al. 2020; Carfi et al. 2020).”
BackgroundThe Role of Bronchoscopy in the Diagnosis and Management of Patients with SARS-Cov-2 Infection
Biondini, D., Damin, M., Bonifazi, M., Cocconcelli, E., Semenzato, U., Spagnolo, P., Gasparini, S., Saetta, M. P., & Balestro, E. (2021) · Diagnostics · doi:10.3390/diagnostics11101938 · Cited by 6
“In the first weeks after the infection, organizing pneumonia (OP) is the prevailing pattern on CT [50]; by contrast, in cohorts with longer follow-up (6 and 12 months), interstitial lung abnormalities (ILAs) and established pulmonary fibrosis tend to prevail [52,53].”
BackgroundCardiovascular COVID‑19 syndrome after‑effects
Bagdasaryan, A. S., Sirunyants, A. A., Pukhnyak, D. V., Kamalyan, Z. A., Remizova, A. I., & Fedisheva, N. A. (2022) · EMERGENCY MEDICAL CARE · doi:10.24884/2072-6716-2022-23-1-19-26 · Cited by 5
Teixido, L., Andreeva, E., Gartmann, J., Lemhöfer, C., Sturm, C., & Gutenbrunner, C. M. (2023) · Laryngo-Rhino-Otologie · doi:10.1055/a-1985-0450 · Cited by 5
“[18] Mandal S, Barnett J, Brill SE et al.”
BackgroundOnieva, A. R., Basurte, C. V., Bersabé, A. F., Cerro, L. C., Bascón, B. V., Sanjuan, N. M., Castro, C. A. S., Morales, V. G., Ruiz, F. P., & Requena, A. H. (2023) · Journal of Primary Care & Community Health · doi:10.1177/21501319231208283 · Cited by 5
Al-Mozaini, M., Islam, M., Noman, A. S. M., Karim, A. R., Farhat, W. A., Yeger, H., & Islam, S. S. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.835098 · Cited by 5
“This study was approved by the ethics committee of Bangladesh Medical Research Council (BMDC) and Park View Hospital [study # 2021-2023/62(1-20)].”
MethodSevere chronic cough relating to post-COVID-19 interstitial lung disease: a case report
Nguyen‐Ho, L., Nguyen‐Nhu, V., Tran-Thi, T.-T., & Solomon, J. J. (2022) · Asia Pacific Allergy · doi:10.5415/apallergy.2022.12.e42 · Cited by 5
“Cough is one of the most common symptoms in post-COVID-19 patients and is seen not only during a severe episode of acute COVID-19 infection (a brief report of 384 hospitalized patients showing the rate of persistent cough 34% [5]) as well as in mild infection with a reported incidence of 29%–43% [6].”
BackgroundSimons, D., Perski, O., Shahab, L., Brown, J., & Bailey, R. L. (2020) · medRxiv · doi:10.1101/2020.11.26.20238469 · Cited by 7
Long COVID: where do we start with the case definitions?Preprint
Alwan, N. A., & Johnson, L. (2020) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/hndtm · Cited by 5
Follow-up evaluation of long COVID syndrome in patients with SARS-CoV-2 infection
Sevdimbaş, S. H., İnal, A. S., Kuşçu, F., Kurtaran, B., Candevir, A., Taşova, Y., & Kömür, S. (2025) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-0046-2025 · Cited by 4
Prevalence and characteristics of post-acute sequelae of COVID-19 in recovered patients
Dale, Z., Wallington, S. F., & Penn-Marshall, M. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1648961 · Cited by 4
Sexton, K. W., Berill, Z., Susi, A., Coene, J., Madison, K. E., & Nylund, C. M. (2025) · Metabolites · doi:10.3390/metabo15120795 · Cited by 4
Gürsoy, E., & Eren, S. (2023) · Eurasian Journal of Family Medicine · doi:10.33880/ejfm.2023120307 · Cited by 5
Püntmann, V. O., Beitzke, D., Kammerlander, A. A., Voges, I., Gabbert, D. D., Dörr, M., Chamling, B., Bozkurt, B., Kaski, J. C., Spatz, E. S., et al. (2024) · Journal of Cardiovascular Magnetic Resonance · doi:10.1016/j.jocmr.2024.101121 · Cited by 4
Anti-inflammatory Potential of Lead Compounds and Their Derivatives from Medicinal Plants
Nirmala, N. S., Navina, B., Vivekanandan, V., & Thirugnanasambantham, K. (2023) · Springer eBooks · doi:10.1007/978-3-031-28780-0_50 · Cited by 4
Visual analysis of hotspots and trends in long COVID research based on bibliometric
Lai, Z., Pu, T., Li, J., Bai, F., Wu, L., & Tang, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e24053 · Cited by 5
“Swapna Mandal found that blood biomarkers (d-dimer and C reactive protein) and chest X-ray imaging were meaningful examinations for early detection of long COVID through follow-up of persistent symptoms after hospitalization with COVID-19 [65].”
BackgroundCovid persistente y discapacidad
Suárez, D., Pascual, E., & Soravilla, J. R. (2024) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2023.102189 · Cited by 6
Bobowik, P. Ż., Gajewski, J., Wiszomirska, I., Maciejewska, A., Leźnicka, K., & Kaczmarczyk, K. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13102747 · Cited by 3
A Systematic Review and Meta-analysis to Identify Risk Factors for Developing Long COVID-19
Muley, A., Mitra, S., Bhaliya, B., Soni, S., & Joshi, A. (2024) · Journal of the Association of Physicians of India · doi:10.59556/japi.72.0528 · Cited by 6
“18,19 22 In a meta-analysis, fatigue, headache, attention disorder, hair loss, and dyspnea were the most common features of long COVID-19 and were seen in 58, 44, 27, 25, and 24%, respectively.”
BackgroundAdvance in the mechanism and clinical research of myalgia in long COVID
Zhai, X. (2024) · American journal of clinical and experimental immunology. · doi:10.62347/txvo6284 · Cited by 6
Mirzapour, F., Shamsipur, M., Ahanjan, K., & Pashabadi, A. (2024) · Microchemical Journal · doi:10.1016/j.microc.2024.111955 · Cited by 4
Fésü, D., Bárczi, E., Csoma, B., Polivka, L., Boga, M., Horváth, G., Varga, J. T., Sebők, S., & Müller, V. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-024-10398-w · Cited by 4
Cossu, G., Kalcev, G., Primavera, D., Lorrai, S., Perra, A., Galetti, A., Demontis, R., Tramontano, E., Bert, F., Montisci, R., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14155363 · Cited by 3
“Contrary to psychosomatic interpretations, over one-third of patients with post-COVID fatigue exhibit persistently elevated D-dimer levels, and 10% have increased C-reactive protein levels, suggesting an ongoing inflammatory process [15].”
Who Gets Cured? COVID-19 and Developing a Critical Medical Sociology and Anthropology of Cure
Berghs, M. J. (2021) · Frontiers in Sociology · doi:10.3389/fsoc.2020.613548 · Cited by 4
“, post-traumatic stress disorder) with physical and psycho-social long-term rehabilitative needs (Halpin et al., 2020; Mandal et al., 2020).”
BackgroundTeixido, L., Andreeva, E., Gartmann, J., Lemhöfer, C., Sturm, C., & Gutenbrunner, C. M. (2022) · Physikalische Medizin Rehabilitationsmedizin Kurortmedizin · doi:10.1055/a-1820-7396 · Cited by 4
European Psychiatric Association–European Academy of Neurology statement on post-COVID syndrome
Bassetti, C. L., Helbok, R., Adorjan, K., & Falkai, P. (2022) · European Psychiatry · doi:10.1192/j.eurpsy.2022.2317 · Cited by 4
A Delphi consensus statement for the management of post-COVID interstitial lung disease
Hadda, V., Suri, T. M., Iyer, H. K., Jain, A., Mittal, S., Madan, K., Mohan, A., Bhalla, A. S., Sindhwani, G., Dutt, N., et al. (2022) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2022.2128770 · Cited by 4
“onset, residual radiological pulmonary lesions are commonplace: seen in about 38% of patients on chest radiographs, and 45 to 77% of patients on CT scans of the chest [10,43,51].”
BackgroundIqbal, N., Khanum, I., Kazi, M. A. I., Riaz, S. U., Khawaja, U. A., Awan, S., Irfan, M., Zubairi, A. B. S., & Khan, J. A. (2022) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2022.2412 · Cited by 4
Siddiq, M. A. B., & Rasker, J. J. (2022) · Heart and Mind · doi:10.4103/hm.hm_63_21 · Cited by 4
Role of TGF-β Signaling in Coronavirus Disease 2019
Chen, J., Wu, W., Wang, W., Tang, Y., & Lan, H.-Y. (2022) · Integrative Medicine in Nephrology and Andrology · doi:10.4103/2773-0387.348713 · Cited by 5
Understanding the mechanisms and treatments of long COVID to address future public health risks
Li, B., Bai, J., Xiong, Y., Guo, D., Fu, B., Deng, G., & Wu, H. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122938 · Cited by 4
Platforms for Personalized Polytherapeutics Discovery in COVID-19
Hopkins, C. E., Onweni, C. L., Zambito, V., Fairweather, D., McCormick, K., Ebihara, H., Caulfield, T. R., Zhang, Y. S., & Freeman, W. D. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.166945 · Cited by 4
“Also there is a large fraction of symptomatic individuals who are increasingly recognized as so-called ‘long haulers’ or chronic COVID syndrome who have mild to moderate symptoms that last for months, with neurologic symptoms(7) and othersmanifestations.(8) The complications from COVID-19 comorbidities have overwhelmi…”
Fernández‐de‐las‐Peñas, C., Herrero‐Montes, M., Pargada, D. J. F., Izquierdo‐Cuervo, S., Palacios‐Ceña, D., Arendt‐Nielsen, L., Torres‐Macho, J., & Parás‐Bravo, P. (2022) · Pain Medicine · doi:10.1093/pm/pnac086 · Cited by 4
“Our results agree with previous data also reporting that laboratory biomarkers obtained at hospital admission are not related to other post-COVID symptoms, for example, fatigue [7].”
ResultOngoing Symptoms, Formation of Interstitial Lung Disease and Follow-up Process in PostCOVID-19
Yavuz, M. Y., & Anar, C. M. (2021) · Journal of İzmir Chest Hospital · doi:10.5222/igh.2021.00719 · Cited by 4
Reid, J. C., Costa, A. P., Duong, M., Ho, T. N., Kruisselbrink, R. J., Raina, P. S., Kirkwood, R. N., Jones, A., Corriveau, S., Griffith, L. E., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-053021 · Cited by 4
Spotnitz, M. E., Hripcsak, G. M., Ryan, P. B., & Natarajan, K. (2021) · medRxiv · doi:10.1101/2021.03.19.21253756 · Cited by 4
Bayly, J., Bradshaw, A., Fettes, L., Omarjee, M., Talbot-Rice, H., Walshe, C., Sleeman, K. E., Bajwah, S., Dunleavy, L., Hocaoğlu, M., et al. (2021) · medRxiv · doi:10.1101/2021.04.13.21255380 · Cited by 4
Fogarty, H., Karampini, E., O’Donnell, A. S., Ward, S. E., O’Sullivan, J. M., & O’Donnell, J. S. (2021) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15578 · Cited by 4
Rao, S., Benzouak, T., Gunpat, S., Burns, R. J., Tahir, T. A., Jolles, S. R. A., & Kisely, S. R. (2021) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/c4w7p · Cited by 4
Review of the mechanism of infection induced cerebral small vessel disease
Song, J., Wang, Y., Xie, Z., Wei, J., & Wang, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1594891 · Cited by 4
Du, S., Cui, Z., Xu, X., Liu, T., & Ye, J. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1656713 · Cited by 4
Dreher, M., Grohé, C., Hartmann, N., Kanzler, S., Kraft, K., Sarrazin, C., Doll, M., Spiesshöfer, J., Steiner, S. F., Wöhrle, J., et al. (2022) · Advances in Therapy · doi:10.1007/s12325-022-02135-z · Cited by 3
“COVID symptoms may persist for several weeks after infection [3] and include fatigue, breathlessness and cough [4].”
BackgroundHu, J., Mougiakakou, S. G., Xue, S., Afshar‐Oromieh, A., Hautz, W. E., Christe, A., Sznitman, R., Rominger, A., Ebner, L., & Shi, K. (2023) · The European Physical Journal Plus · doi:10.1140/epjp/s13360-023-03745-4 · Cited by 3
Al-Jahdhami, I., Arshad, H., Omar, H., Bennji, S. M., Nomani, K. A., Ghafri, M. A., Syabi, M. A., Hinai, S. A., & Al‐Mawali, A. (2023) · Oman Medical Journal · doi:10.5001/omj.2023.120 · Cited by 3
Koliopoulos, T., & Мratskova, G. (2023) · International Conference on Virtual Reality · doi:10.1109/icvr57957.2023.10169333 · Cited by 3
Kobayashi, T., Miyaji, C., Habu, H., Horie, Y., & Takao, S. (2024) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph21020217 · Cited by 2
“In contrast to the results of this study, a few studies have reported a trend in post-acute COVID-19 syndrome that can significantly worsen QOL among older people [15,38].”
BackgroundResultPost-COVID Interstitial Lung Disease: How do We Deal with This New Entity?
Yüksel, A., Karadoğan, D., Hürsoy, N., Telatar, T. G., Kose, N., Marım, F., Kaya, İ., Er, A. B., Erçelik, M., Yuluğ, D. P., et al. (2024) · Balkan Medical Journal · doi:10.4274/balkanmedj.galenos.2024.2024-3-82 · Cited by 3
Impact of COVID-19 Pandemic on Incidence and Prevalence of Cough and its Types: A Real-world Study
Vora, A., Jindal, S. K., Thakor, P., Malve, H., & Panchal, R. (2025) · Journal of the Association of Physicians of India · doi:10.59556/japi.73.1026 · Cited by 3
Breathless Aftermath: Post-COVID-19 Pulmonary Fibrosis
Muthiah, D., Vaddadi, K., & Liu, L. (2025) · Viruses · doi:10.3390/v17081098 · Cited by 6
“Furthermore, research revealed that 38% of patients had abnormal chest radiographs around 54 days after being discharged from the hospital, and 9% experienced worsening abnormalities during the study’s follow-up period [45].”
Singh, S. (2021) · European Respiratory Society eBooks · doi:10.1183/2312508x.10024520 · Cited by 3
The effect of SARS-CoV-2 on multi-organ damage and rehabilitation tactics in the post-COVID period
Oynotkinova, O. S., Мацкеплишвили, С. Т., Larina, V. N., Камынина, Н. Н., Karavashkina, E. A., Bralyuk, M. A., Ryzhikh, A. A., Ponomareva, T. A., Бикбаева, Л. И., & Dementieva, A. S. (2022) · Russian Journal of Cardiology and Cardiovascular Surgery · doi:10.17116/kardio202215021202 · Cited by 3
Shin, S. H., & Lee, E. H. (2022) · Research in Community and Public Health Nursing · doi:10.12799/jkachn.2022.33.1.43 · Cited by 3
Post-Covid-19 Immunological Disorder: A Possible Pathological Entity in a 43 Year Old Man
Scarlat, G., Dona, B., Procopiescu, B., & Stoian, M. (2022) · Internal Medicine · doi:10.2478/inmed-2022-0210 · Cited by 3
Health psychology on long COVID: Strategies based on NICE and WHO guidelines recommendations
Romo, J. F. M. (2022) · Salud Mental · doi:10.17711/sm.0185-3325.2022.026 · Cited by 3
“…skin diseases, psoriasis, and lupus‒, nervous system ‒loss of smell, taste and hearing, convulsions, confusion, nerve pain, cognitive impairment‒, and in mental health ‒stress, depression, and anxiety‒ (Mandal et al., 2020; Leta et al., 2021; Silva et al., 2021; The Lancet Neurology, 2021).”
BackgroundCheung, J., Nordmeier, K., Kelland, S., Harrington, M., Williman, J. A., Storer, M., Beaglehole, B., Beckert, L., Chambers, S. T., Epton, M., et al. (2022) · Internal Medicine Journal · doi:10.1111/imj.15930 · Cited by 3
Seidl, H., Schunk, M. V., Le, L. D., Syunyaeva, Z., Streitwieser, S., Berger, U., Mansmann, U., Szentes, B. L., Bausewein, C., & Schwarzkopf, L. (2022) · Value in Health · doi:10.1016/j.jval.2022.08.002 · Cited by 3
Post-COVID-19 effect on biochemical parameters in children: Should we take heed?
Alsufyani, A. A. (2023) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2023.103649 · Cited by 3
Ranieri, J., Guerra, F., Cilli, E., Martelli, A., Capuani, A., & Giacomo, D. D. (2023) · Psychological Reports · doi:10.1177/00332941231177244 · Cited by 3
“…ef fi cacy of pharmacologic treatments, vaccine, telemedicine, psychological supports examining the cause-effect of physical issues on Quality of Life of patients in survivorship almost in adulthood and elderly (Mandal, et al., 2021; Neria et al., 2011; Hempel et al., 2008; Paneroni, et al., 2021).”
Romano, J., Ribeiro, P. F., Alberto, J., Almeida, P., & Dantas, D. (2023) · Acta Médica Portuguesa · doi:10.20344/amp.19382 · Cited by 3
Association between COVID-19 and sexual health: an umbrella review
Liu, W., Jiesisibieke, Z. L., Chien, C., & Tung, T. (2023) · Annals of Medicine · doi:10.1080/07853890.2023.2258902 · Cited by 3
“Other studies have found that COVID-19 may cause a loss of smell and taste, which could negatively affect sexual behavior because sensory sensations are very important during sex [37,38,94,95].”
BackgroundSamaryn, E., Galińska-Skok, B., Nobis, A., Zalewski, D., Maciejczyk, M., Gudowska-Sawczuk, M., Mroczko, B., Zalewska, A., & Waszkiewicz, N. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12227049 · Cited by 3
Benedini, M., Cogliati, M., Lulic-Kuryllo, T., Peli, E., Mombelli, S., Calza, S., Guarneri, B., Cudicio, A., Rizzardi, A., Bertoni, M., et al. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1235734 · Cited by 4
Long COVID: A Narrative Review and Meta-Analysis of Individual Symptom Frequencies
Atchley, R., Strasser, Z. H., Pant, D., Krisnamoorthy, A., Chibnik, L. B., & Karlson, E. W. (2024) · COVID · doi:10.3390/covid4100106 · Cited by 3
A Step Forward in Long COVID Research: Validating the Post-COVID Cognitive Impairment Scale
Mohammadi, S. P., Etesamipour, R., Mercado, F., & Peláez, I. (2024) · European Journal of Investigation in Health Psychology and Education · doi:10.3390/ejihpe14120197 · Cited by 3
“In 2021, the National Institutes of Health (NIH), alongside multicenter studies in the United States and international research, established that these symptoms are more prevalent in patients with a history of severe illness [7,27,28].”
Typical symptoms of common otorhinolaryngological diseases may mask a SARS-CoV-2 infection
Weiss, R., Guchlerner, L., Loth, A. G., Leinung, M., Wicker, S., Kempf, V. A. J., Berger, A., Rabenau, H. F., Ciesek, S., Stöver, T., et al. (2021) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-021-06726-4 · Cited by 3
García, C. A., Cervilla‐Muñoz, E., & Millán-Núñez-Cortés, J. (2021) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2021.02.011 · Cited by 3
Portacci, A., Pierucci, P., Quaranta, V. N., Quaranta, S., Iorillo, I., Locorotondo, C., Buonamico, E., Dragonieri, S., & Carpagnano, G. E. (2022) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2022.2130764 · Cited by 3
“Considering these findings, it would have been reasonable to find an increase in blood inflammatory biomarkers too, as previously reported by some authors [26,27].”
BackgroundResultWang, J. Y., Zong, X. Y., Wu, G. H., Qi, Y. L., Li, H. Z., Ji, X. Y., Tong, L. X., Zhang, L., Yang, M. B., Yang, P. Y., et al. (2022) · PubMed Central · doi:10.3967/bes2022.126 · Cited by 3
“Growing evidence has shown that COVID-19 survivors may experience long-term sequela and affect different organ systems and quality of life([4,15-19]).”
BackgroundDeterminants of 1-Year Adverse Event Requiring Re-Hospitalization in COVID-19 Oldest Old Survivors
Okoye, C., Franchi, R., Calabrese, A. M., Morelli, V., Peta, U., Mazzarone, T., Pompilii, I. M., Coppini, G., Rogani, S., Calsolaro, V., et al. (2023) · Geriatrics · doi:10.3390/geriatrics8010010 · Cited by 3
Effect of post‐COVID ‐19 condition on sleep: A case report
Albtoosh, A. S., Matar, S. G., Bishtawi, S. N., Elshanbary, A. A., Ramadan, L., Bradbeer, A., Hasabo, E. A., & Basheti, I. A. (2023) · Clinical Case Reports · doi:10.1002/ccr3.7149 · Cited by 3
Matsushima, S., Kasahara, Y., Aikawa, S., FUZIMURA, T., Yokoyama, H., & Katata, H. (2021) · Physical Therapy Research · doi:10.1298/ptr.e10083 · Cited by 3
COVID-19 and Therapeutic Apheresis
Tselmin, S., Julius, U., Jarzebska, N., & Rodionov, R. N. (2022) · Hormone and Metabolic Research · doi:10.1055/a-1864-9482 · Cited by 3
Neurological manifestations in patients with new coronavirus infection COVID-19
Sсherbak, S. G., Голота, А. С., Kamilova, Т. A., Vologzhanin, D. A., & Макаренко, С. В. (2022) · Physical and rehabilitation medicine medical rehabilitation · doi:10.36425/rehab109952 · Cited by 3
Impact of Long-COVID on Health-related Quality of Life in Japanese COVID-19 PatientsPreprint
Tsuzuki, S., Miyazato, Y., Terada, M., Morioka, S., Ohmagari, N., & Beutels, P. (2021) · Research Square · doi:10.21203/rs.3.rs-948458/v1 · Cited by 3
Nair, C. V., Moni, M., Edathadathil, F., Appukuttan, A., Prasanna, P., Roshni, P. R., & Sathyapalan, D. T. (2021) · Research Square · doi:10.21203/rs.3.rs-1161607/v1 · Cited by 3
“A similar study conducted in the UK by Mandal S et al revealed 69% of survivors had persistent fatigue, 53% had dyspnoea and 34% had dry cough 54 days post-discharge [17].”
ResultStewart, I. D., Jacob, J., George, P., Molyneaux, P. L., Porter, J. C., Allen, R., Baillie, J. K., Barratt, S., Beirne, P., Bianchi, S., et al. (2022) · medRxiv · doi:10.1101/2022.03.10.22272081 · Cited by 3
“Long term symptoms of COVID-19 have been widely reported and can have a severe impact on quality of life, frequently characterized by chronic breathlessness.[1-3] Post-mortem studies on COVID-19 patients have highlighted diffuse parenchymal alterations, including alveolar damage, exudation, and development of pulmonar…”
BackgroundPaul, E., & Fancourt, D. E. (2022) · medRxiv · doi:10.1101/2022.04.12.22273792 · Cited by 3
Impact of long-COVID on health-related quality of life in Japanese COVID-19 patientsPreprint
Tsuzuki, S., Miyazato, Y., Terada, M., Morioka, S., Ohmagari, N., & Beutels, P. (2021) · medRxiv · doi:10.1101/2021.09.27.21264225 · Cited by 3
Siamisang, K., Mokgethi, N., Nthibo, L. A., Boitshwarelo, M., & Lesetedi, O. (2024) · Pan African Medical Journal · doi:10.11604/pamj.2024.47.152.40908 · Cited by 2
“The COVID-19 pandemic poses a public mental health challenge with certain groups at the highest risk [11].”
BackgroundBanihashemi, Z.-S., Azizi-Fini, I., Rajabi, M., Maghami, M., & Yadollahi, S. (2024) · BMJ Supportive & Palliative Care · doi:10.1136/spcare-2023-004595 · Cited by 2
Bronchodilator Response in Post-COVID-19 Patients Undergoing Pulmonary Rehabilitation
Krooss, S. A., Klefenz, I., Ott, M., Klawonn, F., Leitl, D., Schneeberger, T., Jarosch, I., Vogelmeier, C. F., Lommatzsch, M., Gloeckl, R., et al. (2024) · Respiration · doi:10.1159/000540297 · Cited by 2
“These complications extend beyond the acute phase and encompass a range of issues, including psychological symptoms such as depression, hemostatic dysregulation, and notably, persistent dyspnea and fatigue [3, 4].”
An, H. J., Li, T., Yang, L., Zhang, X., Hu, H., Zhang, C., Wang, Y., Jin, S., & Li, M. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1498491 · Cited by 2
“Conversely, when platelets were reintroduced in platelet-depleted mice, the number of CD8 T cells in the spleen and liver increased after an infection with lymphocytic choriomeningitis virus (Mandal et al., 2021).”
Cardio-Respiratory Fitness and Fatigue in Post-COVID-19 Syndrome—A Three-Year Update
Cherneva, R. V., Cherneva, Z. V., Youroukova, V., Kadiyska, T., Valev, D., Hayrula-Manaf, E. M., & Mitev, V. (2025) · Biomedicines · doi:10.3390/biomedicines13051097 · Cited by 2
“A lot of research has focused on the long-term sequelae of COVID-19; several reports demonstrate the presence of symptoms in subjects recovering from COVID-19, even in those with milder disease [4].”
Bonnefoy, P. B., Pascal, P., Ceyrat, Q., Burg, S., Razzouk‐Cadet, M., Moreau-Triby, C., Mounicq, I. B., Bourre, J. C., Salaün, P., & Roux, P. L. (2025) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-025-07374-0 · Cited by 2
“Long-term organ damage resulting from the acute illness may also contribute to persistent symptoms [9, 10] while psychological factors and maladaptive processes could play a role as well [11].”
Dysregulated monocyte compartment in PACS patients
Kronstein‐Wiedemann, R., Teichert, M., Michel, E., Berg, J., Robinson, G., Tausche, K., Kolditz, M., Bergleiter, J., Thiel, J., Koschel, D., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1613034 · Cited by 2
Han, X., Wu, L., Wei, X., Wu, F., Kang, S., Xu, W., Hu, S., Tian, R., Zhao, H., Wu, G., et al. (2025) · Information Fusion · doi:10.1016/j.inffus.2025.103535 · Cited by 2
Su, S., Jiang, Z., Shi, L., Liu, X., Zhang, Z., Mei, H., Gao, N., Wu, S., Li, M., Zhang, X., et al. (2025) · BMC Medicine · doi:10.1186/s12916-025-04322-5 · Cited by 2
“The observation of an elevated rate of seropositivity of CRP in reinfection than in Omicron infection also suggests that persistent CRP may be a feature of long COVID [16].”
Cardiovascular sequelae of Long COVID: immune dysregulation inflammation as central drivers
Liu, A., Chen, H., Liu, Q. Y., Al-Azab, M., Shaher, F., Li, J., Liu, T., & Yang, M. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1815269 · Cited by 3
“Similarly, a multicenter and cross-sectional study involving 384 COVID-19 patients 4-6 weeks after discharge reported that 30.1% had persistently elevated D-dimer levels (82).”
InfluentialDutta, A., Mitra, S., & Mitra, D. (2022) · Journal of Health and Allied Sciences NU · doi:10.1055/s-0042-1749182 · Cited by 2
Issues related to post-COVID-19 syndrome
Özdemır, Ö., & Arslan, Z. (2022) · World Journal of Methodology · doi:10.5662/wjm.v12.i4.224 · Cited by 2
Symptoms in the Long Period after the Coronavirus Infection: Results of Long-Term Follow-Up
Всеволодович, М. А., Agaeva, A. I., & Nikitin, I. G. (2022) · The Russian Archives of Internal Medicine · doi:10.20514/2226-6704-2022-12-4-302-309 · Cited by 2
Metadata
- Authors
- Mandal, S., Barnett, J., Brill, S. E., Brown, J. S., Denneny, E. K., Hare, S. S., Heightman, M., Hillman, T. E., Jacob, J., Jarvis, H. C., Lipman, M. C. I., Naidu, S. B., Nair, A., Porter, J. C., Tomlinson, G. S., & Hurst, J. R.
- Affiliations
- Royal Free London NHS Foundation Trust (GB)
- University College London Hospitals NHS Foundation Trust (GB)
- University College Hospital (GB)
- Corresponding author
- Hurst, John R
- ORCID
- Venue
- Thorax
- Publisher
- BMJ
- Published
- 2020-11-10
- Volume
- 76
- Issue
- 4
- Pages
- 396-398
- ISSN
- 0040-6376 (ISSN-L)
- 1468-3296
- PMC
- PMC7615158
- OpenAlex
- W3101401355
- Cited by
- 864
- References
- 7
- Citations by year
- 2026: 18 · 2025: 50 · 2024: 111 · 2023: 181 · 2022: 263 · 2021: 235 · 2020: 6
- FWCI
- 74.15
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Thorax (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Wellcome Trust (Z/17/Z, 209553, 209553/Z/17/Z)
- National Institute for Health and Care Research
- University College London Hospitals NHS Foundation Trust
- Medical Research Council (MR/N007727/1)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Social Sciences › Psychology › Clinical Psychology › COVID-19 and Mental Health
- Keywords
- long COVID, persistent symptoms, dyspnea, cough, fatigue, depression, D-dimer, C-reactive protein, biomarkers, chest X-ray abnormalities, post-discharge follow-up, rehabilitation
- MeSH terms
- COVID-19, SARS-CoV-2, Cross-Sectional Studies, Diagnostic Imaging, Female, Hospitalization, Humans, Lung, Male, Middle Aged, Severity of Illness Index, Biomarkers, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
